Rudy is a former Partner at a large law firm and analyst at Avalere Health with more than 12 years of health care policy experience.
Rudy Missmar focuses his practice on navigating the complex reimbursement challenges that innovative medical technologies and services may face. Specifically, Rudy assists clients with coverage issues (i.e., benefit category determinations, LCDs, and NCDs) and handles issues related to coding (i.e., HCPCS, CPT and ICD-10) and payment including pass-through and new technology add-on payments (NTAPs) for new and existing medical technologies and services across all settings.
His clients include pharmaceutical, biotechnology, medical device, and durable medical equipment manufacturers; private equity investors; and professional and trade associations. Rudy’s practice also encompasses payment and regulatory policy affecting hospitals, post-acute care providers and dialysis facilities. He regularly represents clients in matters before Congress, the Centers for Medicare & Medicaid Services (CMS), local Medicare Administrative Contractors, HCPCS Workgroup and the American Medical Association CPT Editorial Panel and Relative-Value Update Committee.
Prior to Lincoln Policy Group, Rudy Missmar was a Partner in the Health Care Group of a prominent international law firm based in Washington D.C. where he worked for 10 years. Rudy also worked as a consultant at Avalere Health in Washington, D.C., where he focused on Medicare and Medicaid policy and reimbursement strategy for drugs and biologicals.
Rudy received his J.D. in 2007 from the Georgetown University Law Center. In 2002, he received a B.A., magna cum laude, from the Georgetown University School of Foreign Service, where he was elected to Phi Beta Kappa and Alpha Sigma Nu.